Paroxetine Oral Tablets (immediate-release) bulk supplier for pharma manufacturers

Paroxetine Oral Tablets (Immediate-Release) 10 mg, 20 mg, 30 mg, 40 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets (immediate-release)

Available Strengths: 10 mg, 20 mg, 30 mg, 40 mg

Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that works by increasing serotonin levels in the brain to enhance mood and reduce anxiety. It is used to treat depression, panic disorder, obsessive-compulsive disorder, generalized anxiety disorder, PTSD, and social anxiety, promoting emotional stability and mental well-being.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Paroxetine immediate-release tablets are FDA-approved in the USA for depression, panic disorder, OCD, PTSD, GAD, and social anxiety disorder. As a selective serotonin reuptake inhibitor (SSRI), it carries a Boxed Warning regarding increased risk of suicidal thoughts in adolescents and young adults. Regulatory oversight includes strict GMP compliance, labeling requirements, and pharmacovigilance obligations, including adverse event reporting. In the EU, paroxetine IR tablets are widely approved by national authorities and/or the EMA for similar indications. Regulatory submissions must include RMPs, PSURs, and quality documentation. Discover global suppliers and compliant dossiers at Pharmatradz.com.

Paroxetine Oral Tablets (Immediate-Release) — third party manufacturing & bulk supply

Paroxetine Oral Tablets (Immediate-Release) 10 mg, 20 mg, 30 mg, 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Paroxetine Oral Tablets (Immediate-Release) is supplied as Oral Tablets (immediate-release) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Paroxetine Oral Tablets (Immediate-Release) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Paroxetine Oral Tablets (Immediate-Relea... →

Back to Listing

Frequently Asked Questions

Paroxetine Oral Tablets (immediate-release) is listed as Oral Tablets (immediate-release) in 10 mg, 20 mg, 30 mg, 40 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Paroxetine Oral Tablets (immediate-release) is referenced against US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®. Reference brands are shown for identification only and remain the property of their respective trademark owners.